Lab2Go, Minicare, Scienion... ADO..., page-33

What was clear to me in the recent video was that mincare is not going to get taken up by hospitals on technical specs alone. Even with the size of Philips, and the footprint they already have in hospitals, no one is going to be interested in this "new market segment" unless it makes a real difference to hospital workflows and clinical outcomes.

So I think that the first real device has to be "just good enough" that doctors will have trust in the results, so that workflows can be optimized without waiting for the lab. That's what the clinical concordance trials are all about. Improving the specs to blow away the competition can wait, so this still points to minimal, or no, involvement from ADO. But, I have to agree with cashman, that the message about what they "can do" or "will do" was a bit confused so maybe I've got the wrong impression.

Exee